A carregar...
State‐of‐the‐art treatment of systemic lupus erythematosus
As glucocorticoids and immunosuppressive drugs are non‐specific therapeutic agents that cause many adverse reactions, the development of biologicals aiming to control specific molecular targets is anticipated for the treatment of systemic lupus erythematosus (SLE). The antibody targeting B cell‐acti...
Na minha lista:
| Publicado no: | Int J Rheum Dis |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7187183/ https://ncbi.nlm.nih.gov/pubmed/32134201 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1756-185X.13817 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|